Skip to main content
Fig. 4 | BMC Musculoskeletal Disorders

Fig. 4

From: Identification and characterization of human nucleus pulposus cell specific serotypes of adeno-associated virus for gene therapeutic approaches of intervertebral disc disorders

Fig. 4

Proliferating NP cells on day 16 after transduction with scAAV6. A viral dose of 5000 vg/c was used to transduce 1 x 105 NP cells with scAAV6 at 50 % confluent and about 95 % viabilily. Images show bright field views of scAAV6 treated and untreated control NP cells on day 16 of post-transduction. Morphological chages were not observed as shown as an example herein. Original magnification: x 20

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us